Healthcare -
Biotechnology - NASDAQ - US
$ 19.335
3.19 %
$ 2.43 B
Market Cap
-10.61
P/E
APLS - NET INCOME
Net Income APLS - Apellis Pharmaceuticals, Inc.
-198 M
LAST VALUE
44.92%
2 YEAR CAGR
8.27%
5 YEAR CAGR
-33.77%
10 YEAR CAGR